Outlook Therapeutics's top three insider shareholders as of March 23, 2026 are Faisal Ghiath Sukhtian (Director, 55.82Mn shares), Pte Ltd. Biolexis (TenPercentOwner, 22.98Mn shares), Arun Kumar Pillai (Director, 22.98Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Faisal Ghiath Sukhtian | 0 | 55,816,786 | 22 Apr, 2022 | |
| Arun Kumar Pillai | 0 | 22,982,529 | 01 Feb, 2022 | |
| Pte Ltd. Biolexis | 22,982,529 | 0 | 22 Apr, 2022 | |
| Ghiath M. Sukhtian | 0 | 13,552,359 | 28 May, 2025 | |
| Ventures Llc Syntone | 1,705,438 | 0 | 17 Apr, 2024 | |
| Jeff Evanson | Chief Commercial Officer | 808,459 | 0 | 11 Mar, 2024 |
| Terry Dagnon | Chief Operations Officer | 653,058 | 0 | 21 Apr, 2023 |
| Faisal Ghiath Sukhtian | 68,000 | 0 | 11 Oct, 2022 | |
| C Russell Iii Trenary | Ceo And President | 54,925 | 0 | 23 Jun, 2022 |
| Yezan Munther Haddadin | 5,049 | 0 | 29 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Oct, 2025 | Yezan Munther Haddadin | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 01 Oct, 2025 | Andong Huang | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 01 Oct, 2025 | Faisal Ghiath Sukhtian | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 01 Oct, 2025 | Gerd Auffarth | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 01 Oct, 2025 | Randy H Thurman | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 01 Oct, 2025 | Julia A Haller | Stock Option (Right to Buy) | A | 286,734 | $0.00 | 286,734 | D | A |
| 03 Oct, 2025 | Yezan Munther Haddadin | Stock Option (Right to Buy) | A | 95,969 | $0.00 | 95,969 | D | A |
| 03 Oct, 2025 | Gerd Auffarth | Stock Option (Right to Buy) | A | 58,648 | $0.00 | 58,648 | D | A |
| 03 Oct, 2025 | Faisal Ghiath Sukhtian | Stock Option (Right to Buy) | A | 117,296 | $0.00 | 117,296 | D | A |
| 03 Oct, 2025 | Julia A Haller | Stock Option (Right to Buy) | A | 58,648 | $0.00 | 58,648 | D | A |
| 03 Oct, 2025 | Andong Huang | Stock Option (Right to Buy) | A | 53,316 | $0.00 | 53,316 | D | A |
| 01 Jul, 2025 | Robert Charles Jahr | Stock Option (Right to Buy) | A | 800,000 | $0.00 | 800,000 | D | A |
| 27 May, 2025 | Ghiath M. Sukhtian | Common Stock | A | 4,285,714 | $1.40 | 13,552,359 | I | A |
| 27 May, 2025 | Ghiath M. Sukhtian | Warrants (right to buy) | A | 8,571,428 | - | 8,571,428 | I | A |
| 17 Jan, 2025 | Ghiath M. Sukhtian | Common Stock | A | 3,458,571 | $2.51 | 9,266,645 | I | M |
| 04 Feb, 2025 | Faisal Ghiath Sukhtian | Stock Option (Right to Buy) | A | 12,323 | $0.00 | 12,323 | D | A |
| 01 Oct, 2024 | Gerd Auffarth | Stock Option (Right to Buy) | A | 56,636 | $0.00 | 56,636 | D | A |
| 01 Oct, 2024 | Randy H Thurman | Stock Option (Right to Buy) | A | 56,636 | $0.00 | 56,636 | D | A |
| 01 Oct, 2024 | Faisal Ghiath Sukhtian | Stock Option (Right to Buy) | A | 56,636 | $0.00 | 56,636 | D | A |
| 01 Oct, 2024 | Andong Huang | Stock Option (Right to Buy) | A | 56,636 | $0.00 | 56,636 | D | A |